Norian currently manufactures orthobiosurgery products that are exclusively distributed by Synthes. As part of the companies’ long-term supply agreement, Kensey Nash will manufacture Norian products and Synthes will exclusively distribute them. The companies also signed a research and development agreement to create certain related future products.
Also, manufacturing of the Norian product will move from a Synthes facility in West Chester, Pa., to a Kensey Nash facility in Exton, Pa., over 18-24 months.
Read the release report on the acquisition of Synthes subsidiary.
Related Articles on Synthes:
Johnson & Johnson’s Synthes Takeover May Spur More Orthopedic Deals
Johnson & Johnson to Acquire Synthes for $21.3B
Johnson & Johnson Shareholders Uphold Use of Animals in Surgery
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
